Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Arya
Arya Behzad, Sunnyvale, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20120122518 | Multimode Communication Device with Shared Signal Path Programmable Filter - A multimode communication device with a shared signal path programmable filter and a method for utilizing a shared signal path programmable filter in a multimode communication device. Various aspects of the present invention comprise a first module adapted to receive a first communication signal (e.g., corresponding to a first communication protocol) and a second module adapted to receive a second communication signal (e.g., corresponding to a second communication protocol). A shared filter, communicatively coupled to the first and second modules, may be adapted to filter the first and/or second communication signals in accordance with a plurality of selectable sets of filter response characteristics (e.g., associated with the first and second communication protocols). A filter control module may be adapted to select a set of filter response characteristics from a plurality of such sets and program the shared filter to filter a communication signal in accordance with the selected set. | 05-17-2012 |
Arya Biragyn, Lutherville, MD US
| Patent application number | Description | Published |
|---|---|---|
| 20090068234 | Methods and compositions for the treatment and prevention of cancer - The instant invention provides compositions for the treatment of cancer. Specifically, the invention provides polypeptides and nucleic acid molecules comprising tumor-associated embryonic antigens, e.g., OFA-iLRP, and chemoattractant ligands, e.g., a proinflammatory chemokine such as MIP3α/CCL20 or β-defensin mDF2β. The invention further provides cancer vaccines and methods for treating subjects having, or at risk of developing, cancer. | 03-12-2009 |
| 20110081370 | Methods and Compositions for Modulating Immune Tolerance - The instant invention provides methods and compositions for modulation of the immune system. Specifically, the invention provides methods and compositions for increasing T cell mediated immune response useful in the treatment of cancer and chronic infection. | 04-07-2011 |
Arya Biragyn, Baltimore, MD US
| Patent application number | Description | Published |
|---|---|---|
| 20100260793 | DEFENSIN-ANTIGEN FUSION PROTEINS - The present invention relates to a vaccine for increasing the immunogenicity of a tumor antigen thus allowing treatment of cancer, as well as a vaccine that increases the immunogenicity of a viral antigen, thus allowing treatment of viral infection, including immunodeficiency virus (HIV) infection. In particular, the present invention provides a fusion protein comprising a defensin fused to either a tumor antigen or viral antigen which is administered as either a protein or nucleic acid vaccine to elicit an immune response effective in treating cancer or effective in treating or preventing viral infection. | 10-14-2010 |
Arya Biragyn, Frederick, MD US
| Patent application number | Description | Published |
|---|---|---|
| 20110110947 | VIRAL CHEMOKINE-ANTIGEN FUSION PROTEINS - The present invention relates to a vaccine for increasing the immunogenicity of a tumor antigen thus allowing treatment of cancer, as well as a vaccine that increases the immunogenicity of a viral antigen, thus allowing treatment of viral infection, including immunodeficiency virus (HIV) infection. In particular, the present invention provides a fusion protein comprising a viral chemokine fused to either a tumor antigen or viral antigen which is administered as either a protein or nucleic acid vaccine to elicit an immune response effective in treating cancer or effective in treating or preventing viral infection. | 05-12-2011 |
| 20110135715 | DEFENSIN-ANTIGEN FUSION PROTEINS - The present invention relates to a vaccine for increasing the immunogenicity of a tumor antigen thus allowing treatment of cancer, as well as a vaccine that increases the immunogenicity of a viral antigen, thus allowing treatment of viral infection, including immunodeficiency virus (HIV) infection. In particular, the present invention provides a fusion protein comprising a defensin fused to either a tumor antigen or viral antigen which is administered as either a protein or nucleic acid vaccine to elicit an immune response effective in treating cancer or effective in treating or preventing viral infection. | 06-09-2011 |
Arya Ohadi Esfahani, Vancouver CA
| Patent application number | Description | Published |
|---|---|---|
| 20100110185 | Method, system and apparatus for monitoring loading of a payload into a load carrying container - A method, apparatus and system for monitoring loading of a payload into a load carrying container is disclosed. The method involves acquiring at least one image of a load transfer container during operation of the load transfer container by a first operator to load the payload into the load carrying container, and wirelessly transmitting an image signal representing the at least one image. The method also involves receiving the image signal and producing a display signal for causing the at least one image to be displayed for viewing by a second operator to facilitate monitoring of the loading of the payload. | 05-06-2010 |